These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 34677658)
1. Right ventricular contractility affects the clinical efficacy of add-on tolvaptan following hospitalization for heart failure in patients with significant tricuspid regurgitation. Hachiya R; Mochizuki Y; Shibakai M; Omomo Y; Kuroki Y; Endo Y; Ichikawa S; Miyazaki H; Chino S; Toyosaki E; Ota M; Fukuoka H; Shinke T Heart Vessels; 2022 May; 37(5):755-764. PubMed ID: 34677658 [TBL] [Abstract][Full Text] [Related]
2. Impact of tolvaptan on improvement of tricuspid regurgitation and right ventricular dimension in patients with right-sided heart failure. Murakami T; Nakamura N; Natsumeda M; Matsumoto S; Sakai K; Ohno Y; Nakazawa G; Shinozaki N; Ikari Y Heart Vessels; 2022 Jul; 37(7):1153-1161. PubMed ID: 35050407 [TBL] [Abstract][Full Text] [Related]
3. Tricuspid Regurgitation and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction. Adamo M; Metra M; Claggett BL; Miao ZM; Diaz R; Felker GM; McMurray JJV; Solomon SD; Biering-Sørensen T; Divanji PH; Heitner SB; Kupfer S; Malik FI; Teerlink JR; JACC Heart Fail; 2024 Mar; 12(3):552-563. PubMed ID: 38300212 [TBL] [Abstract][Full Text] [Related]
4. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction. Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD; J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictive factors for clinical outcomes of isolated functional tricuspid regurgitation. Nakagawa S; Takahama H; Hoshino K; Yanagi Y; Irie Y; Moriuchi K; Amano M; Okada A; Amaki M; Kanzaki H; Kusano K; Noguchi T; Yasuda S; Izumi C J Cardiol; 2023 Jul; 82(1):8-15. PubMed ID: 36565994 [TBL] [Abstract][Full Text] [Related]
6. Presence of ´isolated´ tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction. Mascherbauer J; Kammerlander AA; Zotter-Tufaro C; Aschauer S; Duca F; Dalos D; Winkler S; Schneider M; Bergler-Klein J; Bonderman D PLoS One; 2017; 12(2):e0171542. PubMed ID: 28199339 [TBL] [Abstract][Full Text] [Related]
7. Tricuspid regurgitation in elderly patients with acute heart failure: insights from the KCHF registry. Obayashi Y; Kato T; Yaku H; Morimoto T; Seko Y; Inuzuka Y; Tamaki Y; Yamamoto E; Yoshikawa Y; Kitai T; Taniguchi R; Iguchi M; Kato M; Takahashi M; Jinnai T; Ikeda T; Nagao K; Kawai T; Komasa A; Nishikawa R; Kawase Y; Morinaga T; Su K; Kawato M; Inoko M; Toyofuku M; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Shizuta S; Ono K; Sato Y; Kuwahara K; Ozasa N; Kimura T; ESC Heart Fail; 2023 Jun; 10(3):1948-1960. PubMed ID: 36992608 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and Prognostic Significance of Functional Mitral and Tricuspid Regurgitation Despite Preserved Left Ventricular Ejection Fraction in Atrial Fibrillation Patients. Abe Y; Akamatsu K; Ito K; Matsumura Y; Shimeno K; Naruko T; Takahashi Y; Shibata T; Yoshiyama M Circ J; 2018 Apr; 82(5):1451-1458. PubMed ID: 29553091 [TBL] [Abstract][Full Text] [Related]
9. Predictability of tricuspid annular plane systolic excursion for the effectiveness of tolvaptan in patients with heart failure. Niwa T; Waseda K; Mizuno T; Nakano Y; Mukai K; Wakabayashi H; Watanabe A; Ando H; Takashima H; Amano T J Echocardiogr; 2017 Sep; 15(3):118-126. PubMed ID: 28194742 [TBL] [Abstract][Full Text] [Related]
10. Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Mohammed SF; Hussain I; AbouEzzeddine OF; Takahama H; Kwon SH; Forfia P; Roger VL; Redfield MM Circulation; 2014 Dec; 130(25):2310-20. PubMed ID: 25391518 [TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of tricuspid valve regurgitation in pulmonary arterial hypertension. Chen L; Larsen CM; Le RJ; Connolly HM; Pislaru SV; Murphy JG; McGoon MD; Frantz RP; Kane GC Clin Respir J; 2018 Apr; 12(4):1572-1580. PubMed ID: 28905517 [TBL] [Abstract][Full Text] [Related]
12. A Prospective, Multicenter, Post-Marketing Surveillance Study to Evaluate the Safety and Effectiveness of Tolvaptan in Patients with Reduced, Preserved, and Mid-Range Ejection Fraction Heart Failure. Kinugawa K; Sato N; Inomata T; Yasuda M; Shimakawa T; Fukuta Y Int Heart J; 2019 Sep; 60(5):1123-1130. PubMed ID: 31484861 [TBL] [Abstract][Full Text] [Related]
13. Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction. Kresoja KP; Lauten A; Orban M; Rommel KP; Alushi B; Besler C; Braun D; Unterhuber M; Stangl K; Landmesser U; Massberg S; Thiele H; Hausleiter J; Lurz P Eur J Heart Fail; 2020 Oct; 22(10):1817-1825. PubMed ID: 32741057 [TBL] [Abstract][Full Text] [Related]
14. Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC-HFA Heart Failure Long-Term Registry. Adamo M; Chioncel O; Benson L; Shahim B; Crespo-Leiro MG; Anker SD; Coats AJS; Filippatos G; Lainscak M; McDonagh T; Mebazaa A; Piepoli MF; Rosano GMC; Ruschitzka F; Savarese G; Seferovic P; Shahim A; Popescu BA; Iung B; Volterrani M; Maggioni AP; Metra M; Lund LH Eur J Heart Fail; 2023 Jul; 25(7):1061-1071. PubMed ID: 37365841 [TBL] [Abstract][Full Text] [Related]
15. Transcatheter Edge-to-Edge Tricuspid Repair for Severe Tricuspid Regurgitation Reduces Hospitalizations for Heart Failure. Orban M; Rommel KP; Ho EC; Unterhuber M; Pozzoli A; Connelly KA; Deseive S; Besler C; Ong G; Braun D; Edwards J; Miura M; Gülmez G; Stolz L; Gavazzoni M; Zuber M; Orban M; Nabauer M; Maisano F; Thiele H; Massberg S; Taramasso M; Fam NP; Lurz P; Hausleiter J JACC Heart Fail; 2020 Apr; 8(4):265-276. PubMed ID: 32241534 [TBL] [Abstract][Full Text] [Related]
16. Impact of tricuspid regurgitation on survival in patients with heart failure: a large electronic health record patient-level database analysis. Messika-Zeitoun D; Verta P; Gregson J; Pocock SJ; Boero I; Feldman TE; Abraham WT; Lindenfeld J; Bax J; Leon M; Enriquez-Sarano M Eur J Heart Fail; 2020 Oct; 22(10):1803-1813. PubMed ID: 32367642 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the get with the guidelines-heart failure (GWTG-HF) risk score in patients undergoing trans-catheter tricuspid valve repair (TTVR). Kavsur R; Hupp-Herschel HE; Sugiura A; Tanaka T; Öztürk C; Weber M; Nickenig G; Tiyerili V; Becher MU Heart Vessels; 2021 Dec; 36(12):1903-1910. PubMed ID: 34023969 [TBL] [Abstract][Full Text] [Related]
18. Experience with long-term administration of tolvaptan to patients with acute decompensated heart failure. Kiuchi S; Fujii T; Hisatake S; Kabuki T; Takashi O; Dobashi S; Ikeda T Drug Discov Ther; 2017 Jul; 11(3):133-139. PubMed ID: 28626112 [TBL] [Abstract][Full Text] [Related]
19. Impact of renal function on mid-term outcomes in heart failure patients treated with tolvaptan. Fujioka K; Mizuno S; Ichise T; Matsui T; Hirase H; Yamaguchi M; Aoyama T; Yamagishi M; Fujino N; Kawashiri MA; Hayashi K Ther Adv Cardiovasc Dis; 2019; 13():1753944718819064. PubMed ID: 30803403 [TBL] [Abstract][Full Text] [Related]
20. Impact of New Grading System and New Hemodynamic Classification on Long-Term Outcome in Patients With Severe Tricuspid Regurgitation. Omori T; Uno G; Shimada S; Rader F; Siegel RJ; Shiota T Circ Cardiovasc Imaging; 2021 Feb; 14(2):e011805. PubMed ID: 33517670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]